Navigation Links
Mr. Robert Andrews Joins Asymchem Life Science (Tianjin) Co. Ltd. as Vice President of Quality Assurance
Date:3/25/2011

MORRISVILLE, N.C., March 25, 2011 /PRNewswire/ -- Asymchem Life Science (Tianjin) Co. Ltd, a leading research-based contract manufacturer of advanced intermediates and API's to the pharmaceutical industry, with sites in the U.S. and China, is pleased to announce the recent addition of Mr. Robert Andrews as Vice President of Quality Assurance as of March 1, 2011.

Mr. Andrews brings to the table over 18 years' experience in the pharmaceutical industry (early and late stage), in quality assurance and quality control. Prior to Asymchem, he worked for solid dosage softgel and softlet manufacturer Banner Pharmacaps, Inc. as a part of their Global Technical Support Management at a total of five plants worldwide. Additionally, Mr. Andrews has worked in many medical and pharmaceutical enterprises in positions such as Senior Consultant of Quality Management at TSI Health Sciences, Inc and Division Quality Manager at Pridecraft Enterprises.

In his previous role, while focusing on quality management and supervision, he handled twenty US FDA, NCDA and DEA Inspections. He has offered technical support and quality management to six API plants and seven solid dosage facilities located throughout China, establishing an experienced foundation for his work coming into Asymchem.

As Vice President of Quality Assurance, Mr. Andrews will have overall responsibility for Asymchem's quality assurance program and management, improving upon Asymchem's cGMP QA management system to align and communicate with customers closely on quality issues. In addition, Mr. Andrews will be responsible for organizing and implementing training with regards to GMP and quality management throughout Asymchem.

"I am very pleased to have Mr. Andrews on board to help strengthen and expand Asymchem's established Quality Assurance program," states Dr Hao Hong, CEO of Asymchem. "With his broad experience in the regulatory and pharmaceutical industry, and proven track record of quality management in API manufacturing, I am confident that our QA program will stay on course for continual improvement."

Asymchem is a leading research-based contract manufacturer specializing in the development and compliant manufacturing (Contract Research and Manufacturing Services) of API's and Drug Products serving the pharmaceutical industry. With a 15 year track record, Asymchem is committed to the highest level of quality and excellence in the integrated CMC services arena. For further information, please visit the Asymchem website at www.asymchem.com.


'/>"/>
SOURCE Asymchem Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. SGS Robert Burek to Speak at Medical Device Standards Seminar March 24
2. Polaris Group Appoints Robert E. Hoffman as Chief Financial Officer
3. Valeant Pharmaceuticals Announces Appointment of Robert A. Ingram and Resignation of William M. Wells as Chairman
4. Uroplasty Announces Addition of Robert Kill to its Board of Directors
5. Laureate Pharma Launches New Regulatory Affairs Services and Appoints Robert G. Burford, Ph.D., as Vice President
6. CNBC, Discovery Channel and National Geographic to Cover Dr. Robert Melamede and Richard Cowan of Cannabis Science Whom are Speaking at The Marijuana Conference in New York City on Oct. 25 & 26
7. CVS Caremark Appoints Jonathan C. Roberts as PBM Chief Operating Officer
8. Dr. Robert Shorr, Leading Scientist in Cancer Metabolism, to Speak at Two Upcoming Pharmaceutical Conferences
9. Media Statement: Robert Moussa, President and CEO, Dilon Diagnostics
10. North American Spine Welcomes Robert R. Bulger, M.D. to Dallas Physician Group
11. Watson Promotes Robert Stewart to Executive Vice President, Global Operations
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/4/2016)... 4, 2016 Frontier Pharma: Chronic Obstructive ... Innovation Chronic Obstructive Pulmonary Disease ... inflammation of the airways and lungs. Persistent breathing ... the disease one of the leading causes of ... the world. COPD is linked to cumulative exposure ...
(Date:2/4/2016)... Feb. 4, 2016  Aethlon Medical, Inc. (Nasdaq: ... biofiltration devices to treat life-threatening diseases, today announced ... ended December 31, 2015. --> ... set forth in our last quarterly call, we ... our long-term objective to establish the Aethlon Hemopurifier® ...
(Date:2/4/2016)...  Blueprint Medicines Corporation (NASDAQ: BPMC ), ... investigational kinase medicines for patients with genomically defined ... of directors of Lonnel Coats , a ... industry-related experience. Jeffrey Albers , ... strategic experience developing and commercializing numerous oncology products ...
Breaking Medicine Technology:
(Date:2/6/2016)... ... February 06, 2016 , ... Shark Finds ... the launch of a new DRTV campaign with Belly Bands. , Having a dog ... from sprays to puppy pads and find nothing works, get Belly Bands, the ...
(Date:2/5/2016)... Toronto, Ontario (PRWEB) , ... February 05, 2016 ... ... today announced the availability of the company's lighter, sleeker next generation LYNX VR ... assembly plant. , Improvements in design and manufacturing not only reduce the ...
(Date:2/5/2016)... ... 05, 2016 , ... The Muscular Dystrophy Association and Sailormen ... the 14th annual “Appetite for a Cure” campaign on Feb. 1 to raise ... related diseases that severely limit strength and mobility. , Now through March ...
(Date:2/5/2016)... ... 05, 2016 , ... After years as an active staff surgeon and having ... surgeon Dr. Wayne Carman transitioned to chief of the Division of Plastic Surgery at ... term as chief and began a second three-year term in January of 2016. , ...
(Date:2/5/2016)... ... February 05, 2016 , ... The American public tends to ... may be safer than regular municipal or well water. The recent experience with lead ... Kleyne, could go a long way toward increasing public acceptance of recycled waste water ...
Breaking Medicine News(10 mins):